Blood News and Research

RSS

FDA-approved blood pressure drug reduces cell damage linked to Alzheimer's disease

In laboratory neuronal cultures, an FDA-approved drug used to treat high blood pressure reduced cell damage often linked to Alzheimer's disease, say researchers at Georgetown University Medical Center and the National Institutes of Health.

30 Jan 2016

UI researchers remind US doctors to watch for two diseases that could be passed from mother to child

While world health leaders race to contain the spread of the mosquito-borne Zika virus in the Americas, researchers at the University of Iowa are reminding doctors in the United States to be on the lookout for two other vector-borne and potentially life-threatening diseases that can be passed from mother to child through the placenta.

30 Jan 2016

UCL-led researchers find way to assess viability of induced pluripotent stem cells

A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). Published today in Nature Communications, the team's discovery offers a new way to fast-track screening methods used in stem cell research.

30 Jan 2016

NJHA honors several individuals and organizations with Healthcare Leader Awards

The New Jersey Hospital Association, the state's oldest and largest healthcare trade association, today held its annual awards program to honor several individuals and organizations for their commitment to the state's healthcare system and the patients and communities they serve.

30 Jan 2016

Overall EU cancer, leukaemia mortality rates to fall in 2016

Total cancer-related mortality rates for men and women in the European Union will decline in 2016, say researchers who predict falls in death rates from most neoplasms, including leukaemia.

29 Jan 2016

Neuroprotection powers for phenytoin in acute optic neuritis

Selective sodium channel blockade with the anti-epileptic drug phenytoin protects against acute demyelinating optic neuritis, researchers report.

29 Jan 2016

Adhering to certain diet may help postpone need for dialysis in CKD patients

Adhering to a certain diet may help postpone the need for dialysis in patients with chronic kidney disease (CKD), according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.

29 Jan 2016

Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

Eisai Inc. announced today that the U.S. Food and Drug Administration approved Halaven (eribulin mesylate) Injection (0.5 mg per mL) for the treatment of patients with unresectable or metastatic liposarcoma who have received a prior anthracycline-containing regimen.

29 Jan 2016

New treatment could stop progression of ALS

Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, for nearly two years in one type of mouse model used to study the disease - allowing the mice to approach their normal lifespan.

29 Jan 2016

New SBP research may lead to novel approach to treat heart failure

More than 5 million people in the United States suffer from heart failure, according to the American Heart Association. Less than half of those with heart failure live five years after diagnosis.

29 Jan 2016

Patients sent for unnecessary blood tests before low-risk surgical procedures

Depending on which hospital you go to for your low-risk surgical procedure, you may be 2.4 times more or less likely to be sent for unnecessary blood tests. This is among the findings of a study conducted by researchers from the Institute of Clinical Evaluative Sciences and the Women's College Hospital Institute for Health Systems Solutions and Virtual Care.

29 Jan 2016

Second-hand smoke exposure linked to larger waist, poorer cognition in children

Exposure to second-hand smoke is associated with a larger waist and poorer cognition in children, researchers say.

29 Jan 2016

Genetic mutations could help explain cause of cancer in pediatric patients

Combined whole exome tumor and blood sequencing in pediatric cancer patients revealed mutations that could help explain the cause of cancer or have the potential to impact clinical cancer care in 40 percent of patients in a study led by researchers from Baylor College of Medicine and Texas Children's Cancer Center.

29 Jan 2016

Study finds ethnic differences in coronary heart disease risk within diverse population

In a study of more than 1.3 million Kaiser Permanente members in Northern California that stretched over 10 years, researchers found that blacks, Latinos and Asians generally had lower risk of coronary heart disease compared to whites.

29 Jan 2016

Vitabiotics introduces new Wellkid Multi-vitamin liquid for kids

New to the Wellkid range, Vitabiotics Wellkid Multi-vitamin liquid includes a range of 15 vitamins and minerals to help maintain all round health, with Swiss Alpine malt.

From Vitabiotics Ltd. 29 Jan 2016

New blood clotting analysis system could help determine effects antithrombotic (anti-clotting) drugs

A new blood clotting analysis system designed in Japan makes it easier to determine the effects of taking one or more antithrombotic (anti-clotting) drugs.

29 Jan 2016

Zepatier receives FDA approval for treatment of chronic HCV genotypes 1 and 4 infections

The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients.

29 Jan 2016

Three Case Western faculty members receive funding to develop new diagnostic technologies

Three Case Western Reserve University faculty members have received funding to further develop emerging technologies aimed at malaria, cystic fibrosis, and sickle cell anemia.

29 Jan 2016

AbbVie announces initiation of first Elagolix Phase 3 study in patients with uterine fibroid

AbbVie, in cooperation with Neurocrine Biosciences, Inc., today announced the initiation of the first of two planned Phase 3 clinical studies evaluating the safety and efficacy of Elagolix alone or in combination with add-back therapy compared to placebo.

29 Jan 2016

Halaven (eribulin mesylate) approved for treatment of liposarcoma

The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate), a type of chemotherapy, for the treatment of liposarcoma (a specific type of soft tissue sarcoma) that cannot be removed by surgery (unresectable) or is advanced (metastatic). This treatment is approved for patients who received prior chemotherapy that contained an anthracycline drug.

28 Jan 2016

Blood News and Research

FDA-approved blood pressure drug reduces cell damage linked to Alzheimer's disease

UI researchers remind US doctors to watch for two diseases that could be passed from mother to child

UCL-led researchers find way to assess viability of induced pluripotent stem cells

NJHA honors several individuals and organizations with Healthcare Leader Awards

Overall EU cancer, leukaemia mortality rates to fall in 2016

Neuroprotection powers for phenytoin in acute optic neuritis

Adhering to certain diet may help postpone need for dialysis in CKD patients

Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

New treatment could stop progression of ALS

New SBP research may lead to novel approach to treat heart failure

Patients sent for unnecessary blood tests before low-risk surgical procedures

Second-hand smoke exposure linked to larger waist, poorer cognition in children

Genetic mutations could help explain cause of cancer in pediatric patients

Study finds ethnic differences in coronary heart disease risk within diverse population

Vitabiotics introduces new Wellkid Multi-vitamin liquid for kids

New blood clotting analysis system could help determine effects antithrombotic (anti-clotting) drugs

Zepatier receives FDA approval for treatment of chronic HCV genotypes 1 and 4 infections

Three Case Western faculty members receive funding to develop new diagnostic technologies

AbbVie announces initiation of first Elagolix Phase 3 study in patients with uterine fibroid

Halaven (eribulin mesylate) approved for treatment of liposarcoma

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News